EULAR® 2024 Insights
EULAR® 2024 Insights: Implications of Newly Established Malignancy Screening Guidelines for Idiopathic Inflammatory Myopathies: A Multicentre, International Evaluation of Clinical and Economic Impact by the Myositis Audit and Research Collaborative Group
By
EULAR® 2024 Insights
FEATURING
Jessica Day
By
EULAR® 2024 Insights
FEATURING
Jessica Day
Login to view comments.
Click here to Login